Revolutionizing Healthcare: Rpharmy Unveils Groundbreaking Hazardous Drug Risk Initiative
Rpharmy to showcase innovative hazardous drug risk initiative at Florida Society of Health System Pharmacists…
Pharmaceuticals
Nefecon R Receives NMPA Approval for Production Expansion, Revolutionizing Treatment Options
Nefecon R, a groundbreaking medication, has received approval from the NMPA for production expansion, marking…
Biomark Diagnostics Inc. Expands Specialty Laboratory Services in Quebec to Meet Growing Demand
Biomark Diagnostics Inc. announces the expansion of its specialty laboratory services in Quebec to accommodate…
Pfizer Boosts Annual Profit Forecast Amidst Strong Pharmaceutical Sales
Pfizer increases annual profit forecast due to robust sales of its pharmaceutical products, driven by…
Pfizer Stock Soars: A $1,000 Investment Now Worth Over $114,500
A $1,000 investment in Pfizer stock 20 years ago would be worth over $114,500 today,…
US Healthcare Update: July 2025
The latest news and updates in the US healthcare sector for July 2025, covering regulatory…
Pfizer Posts Strong Q2 Earnings, Reaffirms 2025 Outlook Amidst Growing Demand for Vaccines and Medicines
Pfizer reports better-than-expected Q2 earnings, driven by strong sales of its COVID-19 vaccine and other…
Pfizer Boosts Annual Profit Forecast Amidst Strong Pharmaceutical Sales
Pfizer increases annual profit forecast due to robust sales of its pharmaceutical products, including COVID-19…
Revolutionary Pill-Based Alternative to Injections Developed by Bath Researchers
A team of researchers from the University of Bath has successfully developed a pill-based alternative…